Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL)

K-Number: K191953 · 2019-08-22

Decision Date2019-08-22
Product CodeJWY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) is a medical device manufactured by Biomerieux S.A.. It received FDA 510(k) clearance on 2019-08-22 under approval number K191953. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL)?

ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) is a medical device that received FDA 510(k) clearance on 2019-08-22. It is manufactured by Biomerieux S.A.. The 510(k) number is K191953.

When was ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) approved by the FDA?

ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) received FDA 510(k) clearance on 2019-08-22, under approval number K191953.

What company makes ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL)?

ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) is manufactured by Biomerieux S.A..

What is the FDA product code for ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL)?

The FDA product code for ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) is JWY.

Other Devices by Biomerieux S.A.

View all 10 devices →

Related Devices (Code: JWY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.